Jorge Felix Saucedo, MD, MBA: a conversation with the editor on optimizing antiplatelet and antithrombotic therapy in patients having percutaneous coronary intervention for acute coronary syndromes

首页> 外文期刊>Proceedings / Baylor University Medical Center >Jorge Felix Saucedo, MD, MBA: a conversation with the editor on optimizing antiplatelet and antithrombotic therapy in patients having percutaneous coronary intervention for acute coronary syndromes

【24h】

Jorge Felix Saucedo, MD, MBA: a conversation with the editor on optimizing antiplatelet and antithrombotic therapy in patients having percutaneous coronary intervention for acute coronary syndromes

机译：乔治·费利克斯·索斯多（Jorge Felix Saucedo），医学博士，工商管理硕士：与编辑进行的对话，探讨针对经皮冠状动脉介入治疗急性冠脉综合征的患者优化抗血小板和抗血栓治疗的方法

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Proceedings / Baylor University Medical Center》 |2012年第2期|共页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类医药、卫生;
关键词

相似文献

外文文献
专利

1. Safety of 6-month duration of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndromes: Rationale and design of the Smart Angioplasty Research Team-safety of 6-month duration of Dual Antiplatelet Therapy after percutaneous coronary intervention in patients with acute coronary syndromes ( SMART-DATE) prospective multicenter randomized trial [J] . Lee Joo Myung, Cho Deok-Kyu, Hahn Joo-Yong, The American heart journal . 2016,第期

机译：急性冠状动脉综合征患者经皮冠状动脉干预后6个月持续时间持续时间：理论与设计急性冠状动脉患者急性冠状动脉经皮冠状动脉介入后6个月持续时间急性血管成形术研究团队 - 安全性综合征（智能日期）预期多中心随机试验
2. Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in iTalian cardiac care units Registry [J] . De Luca Leonardo, Musumeci Giuseppe, Leonardi Sergio, Journal of cardiovascular medicine . 2017,第8期

机译：急性冠状动脉综合征患者发生急性冠状动脉干预患者的抗血栓形成策略：从意大利心脏护理单位注册处住院的急性冠状动脉综合征患者中使用的抗血栓形成疗法的见解
3. Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in iTalian cardiac care units Registry [J] . De Luca Leonardo, Musumeci Giuseppe, Leonardi Sergio, Journal of Turbulence . 2017,第8期

机译：急性冠状动脉综合征患者发生急性冠状动脉干预患者的抗血栓形成策略：从意大利心脏护理单位注册处住院的急性冠状动脉综合征患者中使用的抗血栓形成疗法的见解
4. Outcomes of Medical and Interventional Therapy in Elderly Patients with Acute Coronary Syndromes [C] . D.A. Halon, I. Dobrecky-Mery, S. Adawi, International Congress on Coronary Artery Disease . 2003

机译：老年急性冠状动脉综合征的老年患者的医疗和介入治疗结果
5. The Association between Unfractionated Heparin and Bivalirudin Used during Percutaneous Coronary Intervention for Stable Angina and Acute Coronary Syndromes and the In-Hospital and Mortality Outcomes Observed across All Body Mass Index Groups [D] . Chen, Christine. 2021

机译：在所有体重指数群体中观察到稳定冠状动脉干预期间使用经皮冠状动脉介入和急性冠状动脉综合征的冠状动脉介入和医院和死亡率结果之间的联合肝素和Bivalirudin之间的关联
6. Jorge Felix Saucedo MD MBA: a conversation with the editor on optimizing antiplatelet and antithrombotic therapy in patients having percutaneous coronary intervention for acute coronary syndromes [O] . Jorge Felix Saucedo, William Clifford Roberts 2012

机译：乔治·费利克斯·索克斯多（Jorge Felix Saucedo）医学博士工商管理硕士：与编辑进行的对话探讨针对经皮冠状动脉介入治疗急性冠脉综合征的患者优化抗血小板和抗血栓治疗的方法
7. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery [O] . Glenn N. Levine, Eric R. Bates, John A. Bittl, 2016

机译：2016年ACC / AHA指南重点是冠心病患者双抗血小板治疗持续时间的重点：美国心脏病学 - 美国心脏病学院/美国心脏关联工作队的报告临床实践指南：2011年ACCF / AHA / SCAI指南的更新对于经皮冠状动脉干预，2011年冠状动脉旁路接枝外科手术，2012年ACC / AHA / ACP / AATS / PCNA / SCAI / STS指南诊断和管理稳定缺血性心脏病患者，2013年ACCF / AHA指南对于管理ST升高的心肌梗死，2014年AHA / ACC治疗非ST-EXTIVATION急性冠状动脉综合征的患者，2014年ACC / AHA指南围手术期心血管评估和管理患者患者患者

Jorge Felix Saucedo, MD, MBA: a conversation with the editor on optimizing antiplatelet and antithrombotic therapy in patients having percutaneous coronary intervention for acute coronary syndromes

著录项

相似文献

相关主题

期刊订阅